Medication info
Danalya MR Tablet 10/750 mg

Danalya MR Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Korea Hutech Pharmaceuticals Co., Ltd.
Appearance
Yellow oval-shaped controlled-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201307 · Approved 2022.04.04 · Insurance code 649105460

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medication is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse effects associated with metformin. Take 1 tablet of this medication 20/1000mg extended-release tablets once daily. Patients taking this medication 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medication should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medication, the dose may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medication have not been specifically evaluated in patients switching from other glucose-lowering medications. Because this may cause changes in blood glucose control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medication should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Korea Hutech Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is designed as an adjunct for patients with type 2 diabetes who take both teneligliptin and metformin to help regulate blood sugar levels. It is used effectively in conjunction with dietary and exercise therapy to improve blood sugar levels.

How to take

Adult dose

The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medication is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse effects associated with metformin. Take 1 tablet of this medication 20/1000mg extended-release tablets once daily. Patients taking this medication 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medication should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medication, the dose may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medication have not been specifically evaluated in patients switching from other glucose-lowering medications. Because this may cause changes in blood glucose control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medication should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication is prescribed for patients to lower blood sugar levels, particularly those with type 2 diabetes. While taking this medication, a rare but serious condition called lactic acidosis may occur, so caution is advised. Lactic acidosis is a dangerous condition that results from the excessive accumulation of lactic acid in the body, with symptoms including difficulty breathing, muscle pain, weakness, and abdominal pain. Patients with moderate to severe renal impairment, those with heart failure or acute myocardial infarction, and patients with liver dysfunction should not use this medication. Additionally, patients scheduled for tests using radiopaque agents should discontinue this medication 48 hours prior to the test and resume only after confirming normal renal function post-test. Women who are pregnant or may become pregnant, patients with severe infections or trauma, or those in a state of malnutrition should also avoid this medication. This medication may increase the risk of hypoglycemia when used alongside other diabetes medications, so patients should be well-informed about hypoglycemia symptoms and take measures such as consuming sugar immediately if symptoms appear. Side effects such as constipation, abdominal discomfort, headache, and dizziness may occur, so if these symptoms persist, consulting a doctor is recommended. Regular monitoring of kidney function and blood tests, especially vitamin B12 levels, is recommended during the use of this medication. Alcohol consumption may increase the risk of lactic acidosis, so it is advisable to avoid drinking during treatment. Elderly patients or those with impaired kidney function should take this medication with particular caution, and dose adjustment may be necessary. If blisters or skin abnormalities occur during treatment, immediate consultation with a physician is advised, and drug discontinuation should be considered in cases of severe joint pain. In cases of overdose, it is imperative to visit a hospital immediately for appropriate treatment, and blood dialysis may be necessary for drug removal. This medication has not been established for safety and efficacy in children and should not be used in this population. Finally, this medication should be stored out of reach of children, and it is advisable not to transfer it to other containers.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • bowel obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigus-like lesions
  • acute pancreatitis
  • dizziness
Show 171 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • elevated amylase
  • elevated lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium concentration
  • fatigue
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • epigastric pain
  • gastritis
  • headache
  • upper respiratory tract infection
  • tremor
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • decreased vision
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • neutropenia
  • blood sugar abnormalities
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal stenosis
  • spinal disc protrusion
  • spinal disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral stones
  • urinary calculi
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue inflammation
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • sensory disturbances
  • headache
  • muscle weakness
  • low back pain
  • limb pain
  • lumbar spinal stenosis
  • tendonitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformity
  • hypertrophic osteoarthropathy
  • bursitis
  • spinal osteoarthritis
  • spinal disc protrusion
  • spinal disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • shingles
  • upper respiratory tract infection
  • gastroenteritis
  • pneumonia
  • H1N1 influenza
  • bronchitis
  • chronic sinusitis
  • folliculitis
  • cystitis
  • soft tissue inflammation
  • urinary tract infection
  • pharyngitis
  • streptococcal infection
  • tinea pedis
  • subcutaneous abscess
  • Helicobacter pylori gastritis
  • vomiting
  • chronic gastritis
  • epigastric pain
  • stomatitis
  • esophagitis
  • gastrointestinal motility disorder
  • gastrointestinal motility decrease
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • unusual weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • increased blood sugar
  • abnormal sputum
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid damage
  • ligament sprain
  • lip injury
  • bruise
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure sore ulcer
  • hearing loss
  • endolymphatic hydrops
  • ovarian cysts
  • vulvar pruritus
  • menopausal symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and it is recommended to keep it at room temperature between 1 degree Celsius and 30 degrees Celsius. Storing it this way helps maintain the drug's efficacy.

Appearance and packaging

Appearance

Yellow oval-shaped controlled-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.